Last reviewed · How we verify

NCT04173130

Monocentric Feasibility Study for a New Medical Device for the Treatment of Anal Fissure With Botulinum Toxin

Completed NA Last updated 17 November 2020
What this trial tests

NA trial testing Anuscope with needles in Anal Fissure in 4 participants. Completed in 13 November 2020.

Timeline
11 November 2019
Primary endpoint
13 November 2020
13 November 2020

Quick facts

Lead sponsorDieter Hahnloser
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposedevice feasibility
Enrollment4
Start date11 November 2019
Primary completion13 November 2020
Estimated completion13 November 2020
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Dieter Hahnloser

Who can join

Adults 18 to 75, any sex, with Anal Fissure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Monocentric feasibility study for a new device for the treatment of anal fissure with botulinum toxin.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Anal Fissure

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04173130.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing